Upsher-Smith
is a Minnesota-based pharmaceutical company that develops and commercializes generic drugs for the treatment of migraines and seizure disorders... Read moreUpsher-Smith
is a Minnesota-based pharmaceutical company that develops and commercializes generic drugs for the treatment of migraines and seizure disorders... Read more
Chairman & CEO
Taku Nakaoka
News
Mar 24, 2025
PR Newswire
Press Release: Upsher-Smith : PANTHERx Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE (vigabatrin) Oral Solution
Feb 07, 2025
The Business Journals: Minneapolis/St. Paul
Upsher-Smith: Upsher-Smith to close Plymouth facility, lay off employees
Nov 05, 2024
Drug Store News
Upsher-Smith: Upsher-Smith intros generic Zyprexa
Aug 07, 2024
Pharmabiz
Upsher-Smith: UpsherSmith launches Torpenz tablets to treat tuberous sclerosis complex
Jul 08, 2024
Drug Store News
Upsher-Smith: Upsher-Smith receives 2024 ASAP Alliance Excellence Award
Jul 01, 2024
StreetInsider
Press Release: Upsher-Smith : UPSHER-SMITH REINFORCES ITS COMMITMENT TO RARE DISEASE COMMUNITIES THROUGH ENHANCED PROMISE OF SUPPORT PROGRAM
May 21, 2024
Drug Store News
Upsher-Smith: Upsher-Smith named 2024 ASAP Alliance Excellence Award finalist
Apr 18, 2024
Drug Store News
Upsher-Smith: Upsher-Smith previews expansion of rare disease portfolio at 2024 AAN annual meeting
Apr 02, 2024
Contract Pharma
Upsher-Smith: Bora Pharmaceuticals Completes Upsher-Smith Acquisition
Apr 02, 2024
Drug Store News
Upsher-Smith: Upsher-Smith launches generic Tapazole
Upsher-Smith Competitors
1
2
3
4
5
6
7
8
9
10